PTP-1B inhibitors: cyclopenta[d][1,2]-oxazine derivatives

Bioorg Med Chem Lett. 2006 Feb;16(3):499-502. doi: 10.1016/j.bmcl.2005.10.062. Epub 2005 Nov 8.

Abstract

A series of novel cyclopenta[d][1,2]-oxazine derivatives was prepared and evaluated for their inhibitory activity toward protein tyrosine phosphatase 1B (PTP-1B). Compound 6s was found to be an inhibitor of PTP-1B with nanomolar IC(50) value and high level of selectivity over other recombinant phosphatases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclopentanes / chemical synthesis*
  • Drug Design
  • Enzyme Inhibitors / chemical synthesis*
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Inhibitory Concentration 50
  • Oxazines / chemical synthesis*
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1
  • Protein Tyrosine Phosphatases / antagonists & inhibitors*
  • Structure-Activity Relationship
  • Substrate Specificity

Substances

  • Cyclopentanes
  • Enzyme Inhibitors
  • Oxazines
  • PTPN1 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1
  • Protein Tyrosine Phosphatases